Lee Vannajan S, Nimmanpipug Piyarat, Aruksakunwong Ornjira, Promsri Siriporn, Sompornpisut Pornthep, Hannongbua Supot
Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
J Mol Graph Model. 2007 Sep;26(2):558-70. doi: 10.1016/j.jmgm.2007.03.013. Epub 2007 Apr 4.
Molecular dynamics (MD) simulations of the HIV-1 protease (HIVP) complexed with lead fullerene-based inhibitor (diphenyl C60 alcohol) in the three protonated states, unprotonated (Un-), monoprotonated (Mono-), and diprotonated (Di-) states at Asp25 and Asp25' were performed. As the X-ray structure of the investigated complex is not available, it was built up starting with the X-ray crystallographic structure of the HIVP complexed with non-peptide inhibitor (PDB code: 1AID) and that of the diphenyl C60 alcohol optimized using the integrated ONIOM molecular orbital calculations. The inhibitor was, then, introduced into the enzyme pocket using a molecular docking method. Change of the HIVP binding cavity for all three states were evaluated in terms of distance between the two catalytic residues, Asp25 and Asp25' as well as those between the catalytic residues and the flap regions. The torsional angles formed by the O-C-C-O of the two carboxyl groups of the catalytic dyad show the non-planar configuration with the most frequency at about -45 degrees for the Un-, 35 degrees and -95 degrees for the Mono- and 60 degrees for the Di-systems. At equilibrium, different orientations of the fullerene-based inhibitor in the three protonation states were observed. For the Di-state, the OH group of the inhibitor stably forms hydrogen bonds with the two aspartic residues. It turns to the flap region to form hydrogen bonding to the backbone N of Ile50' for the Un-state. In contrast, the OH group turns to locate between the catalytic and the flap region for the Mono-states. Beside the molecular orientation, the rotation of the OH group of the inhibitor in the Un-state was also detected. In terms of solvation, the carboxylate oxygens of the aspartic residues in the Un- and Mono-states were solvated by one to three water molecules while the OH group in these two states was coordinated by one water molecule. This is in contrast to the Di-state in which no water molecule is available in the radius of 5-6A around the oxygen atoms of the carboxylate groups of enzyme and of the OH group of the inhibitor. The simulated results lead to the conclusion that the active site of the HIVP complexed with the diphenyl C60 alcohol is the diprotonation states on Asp25 and Asp25'.
对与基于铅富勒烯的抑制剂(二苯基C60醇)复合的HIV-1蛋白酶(HIVP)在天冬氨酸25和天冬氨酸25'的三种质子化状态,即未质子化(Un-)、单质子化(Mono-)和双质子化(Di-)状态下进行了分子动力学(MD)模拟。由于所研究复合物的X射线结构不可得,它是从与非肽抑制剂复合的HIVP的X射线晶体结构(PDB代码:1AID)以及使用集成ONIOM分子轨道计算优化的二苯基C60醇的结构开始构建的。然后,使用分子对接方法将抑制剂引入酶口袋。根据两个催化残基天冬氨酸25和天冬氨酸25'之间的距离以及催化残基与侧翼区域之间的距离,评估了所有三种状态下HIVP结合腔的变化。催化二元组的两个羧基的O-C-C-O形成的扭转角显示出非平面构型,对于未质子化系统,最频繁出现的角度约为-45度,对于单质子化系统为35度和-95度,对于双质子化系统为60度。在平衡状态下,观察到基于富勒烯的抑制剂在三种质子化状态下的不同取向。对于双质子化状态,抑制剂的OH基团与两个天冬氨酸残基稳定地形成氢键。对于未质子化状态,它转向侧翼区域与Ile50'的主链N形成氢键。相比之下,对于单质子化状态,OH基团转向位于催化区域和侧翼区域之间。除了分子取向,还检测到未质子化状态下抑制剂的OH基团的旋转。在溶剂化方面,未质子化和单质子化状态下天冬氨酸残基的羧酸盐氧被一到三个水分子溶剂化,而这两种状态下的OH基团由一个水分子配位。这与双质子化状态形成对比,在双质子化状态下,在酶的羧酸盐基团的氧原子和抑制剂的OH基团周围5-6埃半径内没有水分子。模拟结果得出结论,与二苯基C60醇复合的HIVP的活性位点是天冬氨酸25和天冬氨酸25'上的双质子化状态。